Urine concentrations of vilanterol after inhaled administration of vilanterol/fluticasone furoate: Defining a urine threshold and decision limit for vilanterol in doping control analysis
Phase of Trial: Phase II
Latest Information Update: 15 Oct 2019
Price : $35 *
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 08 Feb 2019 Status changed from not yet recruiting to recruiting.
- 15 Jan 2019 Planned initiation date changed from 1 Nov 2018 to 1 Feb 2019.
- 25 Oct 2018 New trial record